Episode Details

Back to Episodes
Real-World Evidence: Outcomes When Testing Frequency Increases

Real-World Evidence: Outcomes When Testing Frequency Increases

Published 3 months, 2 weeks ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/real-world-evidence-outcomes-when-testing-frequency-increases

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Real-World Evidence: Outcomes When Visual Field Testing Frequency Increases Visual field testing, also called perimetry, measures areas of vision that a person can and cannot see. It is especially important in glaucoma, because damage to the optic nerve may progress without noticeable symptoms until substantial vision has been lost. The practical question is not simply whether more tests produce more data. It is whether more frequent testing leads to earlier detection of true progression, better treatment decisions, preserved vision, and acceptable safety and workload. The current evidence suggests that increasing testing frequency usually improves the speed and precision of detecting visual field change. However, there is not yet strong proof that more frequent testing alone prevents blindness or improves quality of life. Evidence for home visual field testing used alongside clinic care is encouraging but still based mainly on small, selected studies rather than large comparative outcome trials. Key Findings at a Glance Clinic-based testing every six months detects progression earlier than approximately yearly testing, particularly when overall visual field trends are analyzed. In a large United States claims cohort, the median testing frequency was only 0.63 visual field tests per year, and more than three-quarters of patients had fewer than one test per year. Home testing can provide weekly or monthly measurements, reduce measurement noise, and sometimes identify a concerning change before the next planned clinic visit. Adherence is the main limitation. Short studies often report good participation, but longer studies show that testing frequency commonly declines over time. More frequent testing also produces more apparent progression signals, some of which later disappear. Confirmation rules are therefore essential. Direct evidence that increased testing changes long-term visual outcomes remains limited. Home testing should generally be treated as an adjunct to clinical examination, not a replacement for eye pressure measurement, optic nerve examination, imaging, and standard clinic-based perimetry. What Guidelines Recommend The European Glaucoma Society notes that there is still no definitive evidence showing which combination of tests or testing frequency produces the best patient outcomes at a sustainable cost. Nevertheless, it recommends obtaining enough early visual field measurements to estimate the individual rate of change. Newly diagnosed patients are often recommended to have standard automated perimetry approximately three times per year during the first two years, after which the schedule can be tailored to disease severity and observed progression. European Glaucoma Society guidelines The World Glaucoma Association similarly recommends an intensive early series in people at risk of visual disability. It suggests that lower-risk patients may later be tested about once a year, while higher-risk patients may need testing twice a year or more often if progression is suspected. World Glaucoma Association consensus These recommendations are based largely on the need to establish a reliable baseline and identify fast progression early. They should not be interpreted as a requirement for every patient to have the same schedule. Testing frequency should reflect: Existing visual field damage Rate of previous change Age and e

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us